Likewise, 1-week treatment of tumor-injected C57BL/6 mice with a specific CSF1R antagonist BLZ945 reduced the number of MAMs in the lung without affecting the number of MAMPCs and C-MOs (Figure 4F). Here, CSF1R is linked to neoplasm.